B Resnick - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

B Resnick

Showing results (131-140 of 383) with videos related to

Pageof 39

Sort By:

Internationale Zeitschrift Fur Klinische Pharmakologie, Therapie, Und Toxikologie. International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1971

Narcotic antagonists in the treatment of opiate dependenceM Fink, A Zaks, R B Resnick, et al.

NIDA Research Monograph|April 1, 1982

LAAM instead of take-home methadoneR B Resnick, A M Washton, J Garwood, et al.

Clinical Pharmacology and Therapeutics|September 1, 1976

Naltrexone: disposition, metabolism, and effects after acute and chronic dosingK Verebey, J Volavka, S J Mulé, et al.

Pancreas|April 15, 2015

Mucinous cystic neoplasm of the pancreas with increased IgG4+ plasma cells and histopathologic features of autoimmune pancreatitis/IgG4-related diseaseEvgeny Yakirevich, Kammi J Henriksen, Thomas Miner, et al.

The American Journal of Psychiatry|June 1, 1974

Studies of EN-1639A (naltrexone): a new narcotic antagonistR B Resnick, J Volavka, A M Freedman, et al.

Psychopharmacology Bulletin|April 1, 1979

Increased serum methadone levels in humans during naloxone-precipitated withdrawal [proceedings]R B Resnick, A Washton, K Verebey, et al.

Immunotherapy|April 20, 2012

Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host diseasePanagiotis Tsirigotis, Reuven Or, Igor B Resnick, et al.

Clinical Pharmacology and Therapeutics|April 1, 1977

Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexoneR B Resnick, R S Kestenbaum, A Washton, et al.

Seminars in Interventional Radiology|February 18, 2011

Endovascular repair of aortic disease: a venture capital perspectiveLucas W Buchanan, S William Stavropoulos, Joshua B Resnick, et al.

Seminars in Interventional Radiology|February 18, 2011

Heparin in interventional radiology: a therapy in evolutionStuart B Resnick, Stephanie H Resnick, Joshua L Weintraub, et al.

Pageof 39

Search research articles

Showing results (131-140 of 383) with videos related to

Sort By:

Pageof 39

Internationale Zeitschrift Fur Klinische Pharmakologie, Therapie, Und Toxikologie. International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1971

Narcotic antagonists in the treatment of opiate dependenceM Fink, A Zaks, R B Resnick, et al.

NIDA Research Monograph|April 1, 1982

LAAM instead of take-home methadoneR B Resnick, A M Washton, J Garwood, et al.

Clinical Pharmacology and Therapeutics|September 1, 1976

Naltrexone: disposition, metabolism, and effects after acute and chronic dosingK Verebey, J Volavka, S J Mulé, et al.

Pancreas|April 15, 2015

The American Journal of Psychiatry|June 1, 1974

Studies of EN-1639A (naltrexone): a new narcotic antagonistR B Resnick, J Volavka, A M Freedman, et al.

Psychopharmacology Bulletin|April 1, 1979

Increased serum methadone levels in humans during naloxone-precipitated withdrawal [proceedings]R B Resnick, A Washton, K Verebey, et al.

Immunotherapy|April 20, 2012

Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host diseasePanagiotis Tsirigotis, Reuven Or, Igor B Resnick, et al.